GSK

Existing Drug Combo Shows Potential for First Meth Addiction Treatment
Existing Drug Combo Shows Potential for First Meth Addiction Treatment
BioSpace
meth addiction
GSK
Wellbutrin
Flag link:
GlaxoSmithKline joins Sosei's who's-who list of clients with global licensing pact for IBD small molecules
GlaxoSmithKline joins Sosei's who's-who list of clients with global licensing pact for IBD small molecules
Endpoints
Sosei Heptares
GSK
inflammatory bowel disease
Flag link:
GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients
GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients
Endpoints
GSK
Vir Biotechnology
Eli Lilly
antibodies
NIH
COVID-19
clinical trials
Flag link:
After losing race for first to market in lupus nephritis, Aurinia taps Otsuka for voclosporin licensing pact abroad
After losing race for first to market in lupus nephritis, Aurinia taps Otsuka for voclosporin licensing pact abroad
Endpoints
Aurinia Pharmaceuticals
lupus nephritis
GSK
Otsuka
Benlysta
Flag link:
GSK puts up to $815M on the table for Surface Oncology's antibody
GSK puts up to $815M on the table for Surface Oncology's antibody
Fierce Biotech
GSK
Surface Oncology
SRF813
Flag link:
13 drugmakers contracted by Operation Warp Speed in 2020
13 drugmakers contracted by Operation Warp Speed in 2020
Beckers Hospital Review
HHS
Operation Warp Speed
COVID-19
vaccines
Cytiva
Eli Lilly
AstraZeneca
Emergent BioSolutions
Fujifilm
JNJ
Moderna Therapeutics
Pfizer
BioNTech
Novavax
Regeneron
Sanofi
GSK
Flag link:
Weak clinical data force Sanofi, GSK to delay COVID-19 vaccine
Weak clinical data force Sanofi, GSK to delay COVID-19 vaccine
Fierce Biotech
Sanofi
GSK
vaccines
COVID-19
clinical trials
Flag link:
Clover nears pivotal trial of GSK-adjuvanted COVID-19 vaccine
Clover nears pivotal trial of GSK-adjuvanted COVID-19 vaccine
Fierce Biotech
Clover BioPharmaceuticals
clinical trials
COVID-19
vaccines
GSK
Flag link:
GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study
GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study
Biopharma Reporter
GSK
vaccines
RSV
clinical trials
Flag link:
GSK and ViiV score breakthrough therapy designation in HIV prevention, as Truvada showdown draws nearer
GSK and ViiV score breakthrough therapy designation in HIV prevention, as Truvada showdown draws nearer
Endpoints
GSK
ViiV
FDA
cabotegravir
HIV
PrEP
Flag link:
GSK’s ViiV Healthcare caps virtual HIV summit with a Facebook Live cabaret
GSK’s ViiV Healthcare caps virtual HIV summit with a Facebook Live cabaret
Fierce Pharma
GSK
ViiV
HIV
Facebook
drug marketing
Flag link:
Tapping GSK tech, Medicago kickstarts later-stage COVID vax tests
Tapping GSK tech, Medicago kickstarts later-stage COVID vax tests
Fierce Biotech
GSK
Medicago
clinical trials
vaccines
COVID-19
Flag link:
GSK reports its long-acting HIV PrEP tops Gilead's Truvada — again
GSK reports its long-acting HIV PrEP tops Gilead's Truvada — again
Endpoints
GSK
ViiV
cabotegravir
HIV
PrEP
FDA
Flag link:
Bayer, ViiV and RB challenge limits of pharma marketing creativity with innovative thinking, executions and media
Bayer, ViiV and RB challenge limits of pharma marketing creativity with innovative thinking, executions and media
Fierce Pharma
Bayer
ViiV
Reckitt Benckiser
pharma marketing
GSK
digital marketing
DTC advertising
Flag link:
Sanofi, GSK pledge 200M doses to an international coronavirus vaccine alliance
Sanofi, GSK pledge 200M doses to an international coronavirus vaccine alliance
BioPharma Dive
Sanofi
GSK
COVID-19
vaccines
COVAX
Flag link:
With FDA decision looming, GSK sweetens the PD-1 pot for discovery partner AnaptysBio as Hal Barron moves to guard his oncology strategy
With FDA decision looming, GSK sweetens the PD-1 pot for discovery partner AnaptysBio as Hal Barron moves to guard his oncology strategy
Endpoints
AnaptysBio
GSK
Tesaro
Zejula
Flag link:
GSK sees 'robust immune response' from RSV vaccine hopefuls
GSK sees 'robust immune response' from RSV vaccine hopefuls
Fierce Pharma
GSK
RSV
vaccines
clinical trials
Flag link:
GSK's Emma Walmsley granted damehood by Queen Elizabeth II
GSK's Emma Walmsley granted damehood by Queen Elizabeth II
Endpoints
GSK
Pharma CEOs
Emma Walmsley
Flag link:
GSK, Vir cleared to leap into PhIII, angling for a spot in the Covid-19 antibody race led by Lilly, Regeneron
GSK, Vir cleared to leap into PhIII, angling for a spot in the Covid-19 antibody race led by Lilly, Regeneron
Endpoints
GSK
Vir Biotechnology
COVID-19
clinical trials
Flag link:
Teva back on the hook for $235M to GSK for heart drug infringement
Teva back on the hook for $235M to GSK for heart drug infringement
Fierce Pharma
Teva
GSK
Patent Infringement
Coreg
generics
patents
Flag link:

Pages